4629
DAISHIN CHEMICAL CO.,LTD.
大伸化学
- Industry
- Chemicals
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Consolidation basisConsolidated / Since Mar 2023
Key metrics
Revenue(thousand JPY)
Mar 2021
25,645,706
Mar 2022
31,301,629
Mar 2023
34,391,592
Mar 2024
32,461,797
Mar 2025
34,711,178
Operating profit(thousand JPY)
Mar 2021
1,629,980
Mar 2022
993,696
Mar 2023
1,253,733
Mar 2024
825,737
Mar 2025
799,309
Operating profit margin(%)
Mar 2021
6.36
Mar 2022
3.17
Mar 2023
3.65
Mar 2024
2.54
Mar 2025
2.3
Profit before tax(thousand JPY)
Mar 2021
1,672,446
Mar 2022
1,031,351
Mar 2023
1,309,581
Mar 2024
936,587
Mar 2025
835,486
Profit(thousand JPY)
Mar 2021
1,138,356
Mar 2022
694,138
Mar 2023
955,946
Mar 2024
627,191
Mar 2025
588,158
Total assets(thousand JPY)
Mar 2021
21,032,970
Mar 2022
23,255,636
Mar 2023
24,392,843
Mar 2024
24,132,564
Mar 2025
25,196,175
Cash and cash equivalents(thousand JPY)
Mar 2021
4,404,945
Mar 2022
3,831,060
Mar 2023
4,951,635
Mar 2024
4,107,189
Mar 2025
6,371,465
Cash flows from operating activities(thousand JPY)
Mar 2021
1,589,453
Mar 2022
60,436
Mar 2023
1,798,489
Mar 2024
-185,136
Mar 2025
2,747,131
Cash flows from investing activities(thousand JPY)
Mar 2021
-569,271
Mar 2022
-333,289
Mar 2023
-414,304
Mar 2024
-438,902
Mar 2025
-289,390
Cash flows from financing activities(thousand JPY)
Mar 2021
-332,961
Mar 2022
-301,032
Mar 2023
-263,609
Mar 2024
-220,406
Mar 2025
-193,465
Return on equity(%)
Mar 2021
8.4
Mar 2022
4.9
Mar 2023
6.2
Mar 2024
4
Mar 2025
3.6
Equity ratio(%)
Mar 2021
66.5
Mar 2022
62.4
Mar 2023
63.3
Mar 2024
66.4
Mar 2025
65.6
Earnings per share(JPY per share)
Mar 2021
248.81
Mar 2022
151.72
Mar 2023
208.96
Mar 2024
137.09
Mar 2025
128.55
Net assets per share(JPY per share)
Mar 2021
3,058.05
Mar 2022
3,171.82
Mar 2023
3,375.09
Mar 2024
3,502.03
Mar 2025
3,610.83
Dividend per share(JPY per share)
Mar 2021
39
Mar 2022
32
Mar 2023
40
Mar 2024
40
Mar 2025
40
Payout ratio(%)
Mar 2021
15.67
Mar 2022
21.09
Mar 2023
19.14
Mar 2024
29.18
Mar 2025
31.12
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.